02-05-2025 17:51 via drugs.com

Semaglutide Beneficial in Metabolic Dysfunction-Associated Steatohepatitis, Fibrosis

FRIDAY, May 2, 2025-- For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with improved liver histologic outcomes, according to a study published online April 30 in the New England...
Read more »

Pharmaceutical Industry news



Withdrawal of Flovent Led to Discontinuation of Inhaled Steroids for Children With Asthma
Advanced Biological Age Linked to Increased Risk for Incident Dementia
Gluten-Free Diet for Celiac Disease Increases Arsenic Exposure in Children
Urinary Incontinence Linked to CVD Risk Factors, Comorbid Conditions
No Benefit Seen for Revascularization Added to Drug Therapy in Carotid Stenosis
Buprenorphine for Opioid Use Disorder in Pregnancy Can Improve Outcomes
Exposure to Smoke Pollution Ups Risk for Hospitalization for Respiratory Disease
Estimated 7.2 Million Americans 65 Years and Older Have Alzheimer Dementia
Prior Military Sexual Trauma Linked to Late-Life Suicide Attempt
Study IDs Nonclinical, Modifiable Risk Factors Tied to Sudden Cardiac Arrest
Risk Factors for Alzheimer Disease Linked to Cognitive Function Before Midlife
Peanut Oral Immunotherapy Efficacious in Allergic Adults
Metformin Beneficial for Osteoarthritis Knee Pain in Overweight, Obesity
Hypertensive Disorders of Pregnancy Adversely Affect Preemie Neurodevelopment
Desktop versie